Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy

BACKGROUND: Rhodium (II) citrate (Rh(2)(H(2)cit)(4)) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues of rhodium (II) indicates Rh(2)(H(2)cit)(4 )as a promising agent for c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carneiro, Marcella LB, Nunes, Eloiza S, Peixoto, Raphael CA, Oliveira, Ricardo GS, Lourenço, Luiza HM, da Silva, Izabel CR, Simioni, Andreza R, Tedesco, Antônio C, de Souza, Aparecido R, Lacava, Zulmira GM, Báo, Sônia N
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3073883/
https://ncbi.nlm.nih.gov/pubmed/21443799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-3155-9-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares